KLIMEVRY
LIVE

Serial Number

99835754

Owner

Eli Lilly and Company

Attorney

Tiffany Trunko

Filing Date

May 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KLIMEVRY Trademark

Serial Number: 99835754

KLIMEVRY is a trademark filed by Eli Lilly and Company on May 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Eli Lilly and Company (94 trademarks)

Lilly Corporate Center
Indianapolis, IN 46285

Entity Type: 03

Trademark Details

Filing Date

May 20, 2026

Registration Date

Not Registered

Published for Opposition

August 25, 2026

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, retinal disease, rheumatoid arthritis, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2026 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 31, 2026 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2026 CNSA
ASSIGNED TO EXAMINER
Jul 16, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
May 20, 2026 MAFR
NEW APPLICATION ENTERED
May 20, 2026 NWAP